;PMID: 1946468
;source_file_2908.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..53] = [t:0..53]
;1)sentence:[e:59..184] = [t:59..184]
;2)section:[e:188..248] = [t:188..248]
;3)section:[e:252..328] = [t:252..328]
;4)sentence:[e:332..497] = [t:332..497]
;5)sentence:[e:498..812] = [t:498..812]
;6)sentence:[e:813..1101] = [t:813..1101]
;7)sentence:[e:1103..1221] = [t:1103..1221]
;8)sentence:[e:1222..1409] = [t:1222..1409]
;9)section:[e:1413..1457] = [t:1413..1457]

;section 0 Span:0..53
;Proc Natl Acad Sci U S A.  1991 Nov 15;88(22):9994-8.
(SEC
  (FRAG (NNP:[0..4] Proc) (NNP:[5..9] Natl) (NNP:[10..14] Acad)
        (NNP:[15..18] Sci) (NNP:[19..20] U) (NNP:[21..22] S) (NNP:[23..24] A)
        (.:[24..25] .) (CD:[27..31] 1991) (NNP:[32..35] Nov) (CD:[36..38] 15)
        (CD:[38..41] ;88) (-LRB-:[41..42] -LRB-) (CD:[42..44] 22)
        (-RRB-:[44..45] -RRB-) (CD:[45..50] :9994) (::[50..51] -)
        (CD:[51..53] 8.)))

;sentence 1 Span:59..184
;Insulin-like growth factor I shifts from promoting cell division to
;potentiating  maturation during neuronal differentiation.
;[59..87]:gene-protein:"Insulin-like growth factor I"
(SENT
  (S-HLN
    (NP-SBJ
      (ADJP (NN:[59..66] Insulin) (HYPH:[66..67] -) (JJ:[67..71] like))
      (NML (NN:[72..78] growth) (NN:[79..85] factor))
      (CD:[86..87] I))
    (VP (VBZ:[88..94] shifts)
      (PP (IN:[95..99] from)
        (NP
          (NP (VBG:[100..109] promoting) (NN:[110..114] cell)
              (NN:[115..123] division))
          (PP (TO:[124..126] to)
            (NP (VBG:[127..139] potentiating) (NN:[141..151] maturation)))
          (PP-TMP (IN:[152..158] during)
            (NP (JJ:[159..167] neuronal) (NN:[168..183] differentiation))))))
    (.:[183..184] .)))

;section 2 Span:188..248
;Pahlman S, Meyerson G, Lindgren E, Schalling M, Johansson I.
(SEC
  (FRAG (NNP:[188..195] Pahlman) (NNP:[196..197] S) (,:[197..198] ,)
        (NNP:[199..207] Meyerson) (NNP:[208..209] G) (,:[209..210] ,)
        (NNP:[211..219] Lindgren) (NNP:[220..221] E) (,:[221..222] ,)
        (NNP:[223..232] Schalling) (NNP:[233..235] M,)
        (NNP:[236..245] Johansson) (NNP:[246..248] I.)))

;section 3 Span:252..328
;Department of Pathology, University of Uppsala, University Hospital, Sweden.
(SEC
  (FRAG (NNP:[252..262] Department) (IN:[263..265] of)
        (NNP:[266..275] Pathology) (,:[275..276] ,) (NNP:[277..287] University)
        (IN:[288..290] of) (NNP:[291..298] Uppsala) (,:[298..299] ,)
        (NNP:[300..310] University) (NNP:[311..319] Hospital) (,:[319..320] ,)
        (NNP:[321..327] Sweden) (.:[327..328] .)))

;sentence 4 Span:332..497
;SH-SY5Y neuroblastoma cells undergo neuronal differentiation and their 
;proliferation is inhibited when they are treated with phorbol 12-myristate 
;13-acetate (PMA).
;[340..359]:malignancy-type:"neuroblastoma cells"
(SENT
  (S
    (S
      (NP-SBJ (NN:[332..339] SH-SY5Y)
         (NN:[340..353] neuroblastoma) (NNS:[354..359] cells))
      (VP (VBP:[360..367] undergo)
        (NP (JJ:[368..376] neuronal) (NN:[377..392] differentiation))))
    (CC:[393..396] and)
    (S
      (NP-SBJ-1 (PRP$:[397..402] their) (NN:[404..417] proliferation))
      (VP (VBZ:[418..420] is)
        (VP (VBN:[421..430] inhibited)
          (NP-1 (-NONE-:[430..430] *))
          (SBAR-ADV
            (WHADVP-2 (WRB:[431..435] when))
            (S
              (NP-SBJ-3 (PRP:[436..440] they))
              (VP (VBP:[441..444] are)
                (VP (VBN:[445..452] treated)
                  (NP-3 (-NONE-:[452..452] *))
                  (PP-CLR (IN:[453..457] with)
                    (NP
                      (NP (NN:[458..465] phorbol) (NN:[466..478] 12-myristate)
                          (NN:[480..490] 13-acetate))
                      (NP (-LRB-:[491..492] -LRB-) (NN:[492..495] PMA)
                          (-RRB-:[495..496] -RRB-))))
                  (ADVP-2 (-NONE-:[496..496] *T*)))))))))
    (.:[496..497] .)))

;sentence 5 Span:498..812
;Insulin and insulin-like growth factor I (IGF-I) are mitogens  for the
;nontreated SH-SY5Y cells, whereas the proliferative response to such  factor
;stimulation is lost upon differentiation, in spite of the fact that the 
;receptors for insulin and IGF-I remain expressed and functional in the 
;differentiated cells.
;[498..505]:gene-protein:"Insulin"
;[510..538]:gene-protein:"insulin-like growth factor I"
;[540..545]:gene-protein:"IGF-I"
;[733..740]:gene-protein:"insulin"
;[745..750]:gene-protein:"IGF-I"
(SENT
  (S
    (S
      (NP-SBJ
        (NP (NN:[498..505] Insulin))
        (CC:[506..509] and)
        (NP
          (NP
            (ADJP (NN:[510..517] insulin) (HYPH:[517..518] -)
                  (JJ:[518..522] like))
            (NML (NN:[523..529] growth) (NN:[530..536] factor))
            (CD:[537..538] I))
          (NP (-LRB-:[539..540] -LRB-) (NN:[540..545] IGF-I)
              (-RRB-:[545..546] -RRB-))))
      (VP (VBP:[547..550] are)
        (NP-PRD
          (NP (NNS:[551..559] mitogens))
          (PP (IN:[561..564] for)
            (NP (DT:[565..568] the) (JJ:[569..579] nontreated)
                (NN:[580..587] SH-SY5Y) (NNS:[588..593] cells))))))
    (,:[593..594] ,) (IN:[595..602] whereas)
    (S
      (NP-SBJ-1
        (NP (DT:[603..606] the) (JJ:[607..620] proliferative)
            (NN:[621..629] response))
        (PP (TO:[630..632] to)
          (NP (JJ:[633..637] such) (NN:[639..645] factor)
              (NN:[646..657] stimulation))))
      (VP (VBZ:[658..660] is)
        (VP (VBN:[661..665] lost)
          (NP-1 (-NONE-:[665..665] *))
          (PP (IN:[666..670] upon)
            (NP (NN:[671..686] differentiation)))
          (,:[686..687] ,)
          (PP (IN:[688..690] in)
            (NP
              (NP (NN:[691..696] spite))
              (PP (IN:[697..699] of)
                (NP (DT:[700..703] the) (NN:[704..708] fact)
                  (SBAR (IN:[709..713] that)
                    (S
                      (NP-SBJ
                        (NP (DT:[714..717] the) (NNS:[719..728] receptors))
                        (PP (IN:[729..732] for)
                          (NP (NN:[733..740] insulin) (CC:[741..744] and)
                              (NN:[745..750] IGF-I))))
                      (VP (VBP:[751..757] remain)
                        (ADJP-PRD
                          (ADJP (VBN:[758..767] expressed))
                          (CC:[768..771] and)
                          (ADJP (JJ:[772..782] functional)))
                        (PP-LOC (IN:[783..785] in)
                          (NP (DT:[786..789] the)
                              (VBN:[791..805] differentiated)
                              (NNS:[806..811] cells)))))))))))))
    (.:[811..812] .)))

;sentence 6 Span:813..1101
;Here we show that the PMA-induced differentiation of  SH-SY5Y cells grown in
;a serum-free medium is strongly potentiated by nanomolar  concentrations of
;IGF-I, as judged by morphology and markers for neuronal 
;differentiation--e.g., neuropeptide tyrosine and growth-associated protein
;43.
;[966..971]:gene-protein:"IGF-I"
;[1072..1100]:gene-protein:"growth-associated protein 43"
(SENT
  (S
    (ADVP (RB:[813..817] Here))
    (NP-SBJ (PRP:[818..820] we))
    (VP (VBP:[821..825] show)
      (SBAR (IN:[826..830] that)
        (S
          (NP-SBJ-1
            (NP (DT:[831..834] the)
              (ADJP (NN:[835..838] PMA) (HYPH:[838..839] -)
                    (VBN:[839..846] induced))
              (NN:[847..862] differentiation))
            (PP (IN:[863..865] of)
              (NP
                (NP (NN:[867..874] SH-SY5Y) (NNS:[875..880] cells))
                (VP (VBN:[881..886] grown)
                  (NP (-NONE-:[886..886] *))
                  (PP (IN:[887..889] in)
                    (NP (DT:[890..891] a)
                      (ADJP (NN:[892..897] serum) (HYPH:[897..898] -)
                            (JJ:[898..902] free))
                      (NN:[903..909] medium)))))))
          (VP (VBZ:[910..912] is)
            (ADVP (RB:[913..921] strongly))
            (VP (VBN:[922..933] potentiated)
              (NP-1 (-NONE-:[933..933] *))
              (PP (IN:[934..936] by)
                (NP-LGS
                  (NP (JJ:[937..946] nanomolar) (NNS:[948..962] concentrations))
                  (PP (IN:[963..965] of)
                    (NP (NN:[966..971] IGF-I)))))
              (,:[971..972] ,)
              (SBAR-ADV (IN:[973..975] as)
                (S
                  (NP-SBJ-2 (-NONE-:[975..975] *))
                  (VP (VBN:[976..982] judged)
                    (NP-2 (-NONE-:[982..982] *))
                    (PP-MNR (IN:[983..985] by)
                      (NP
                        (NP (NN:[986..996] morphology) (CC:[997..1000] and)
                            (NNS:[1001..1008] markers))
                        (PP (IN:[1009..1012] for)
                          (NP
                            (NP
                              (NP (JJ:[1013..1021] neuronal)
                                  (NN:[1023..1038] differentiation))
                              (::[1038..1040] --)
                              (NP
                                (ADVP (FW:[1040..1044] e.g.))
                                (,:[1044..1045] ,)
                                 (NN:[1046..1058] neuropeptide)
                                 (NN:[1059..1067] tyrosine)))
                            (CC:[1068..1071] and)
                            (NP
                              (ADJP (NN:[1072..1078] growth)
                                    (HYPH:[1078..1079] -)
                                    (VBN:[1079..1089] associated))
                              (NN:[1090..1097] protein) (CD:[1098..1100] 43))))))))))))))
    (.:[1100..1101] .)))

;sentence 7 Span:1103..1221
;Also, insulin and IGF-II potentiated the phorbol ester-induced
;differentiation,  although less efficiently than IGF-I.
;[1109..1116]:gene-protein:"insulin"
;[1121..1127]:gene-protein:"IGF-II"
;[1215..1220]:gene-protein:"IGF-I"
(SENT
  (S
    (ADVP (RB:[1103..1107] Also))
    (,:[1107..1108] ,)
    (NP-SBJ (NN:[1109..1116] insulin) (CC:[1117..1120] and)
            (NN:[1121..1127] IGF-II))
    (VP (VBD:[1128..1139] potentiated)
      (NP (DT:[1140..1143] the)
        (ADJP
          (NML (NN:[1144..1151] phorbol) (NN:[1152..1157] ester))
          (HYPH:[1157..1158] -) (VBN:[1158..1165] induced))
        (NN:[1166..1181] differentiation))
      (,:[1181..1182] ,)
      (SBAR-ADV (IN:[1184..1192] although)
        (FRAG
          (ADVP (RBR:[1193..1197] less) (RB:[1198..1209] efficiently))
          (PP (IN:[1210..1214] than)
            (NP (NN:[1215..1220] IGF-I))))))
    (.:[1220..1221] .)))

;sentence 8 Span:1222..1409
;Using blocking anti-receptor antibodies,  it could be shown that the
;differentiation induced by these factors, in  combination with PMA, was
;primarily mediated through the IGF-I receptor.
;[1251..1261]:gene-protein:"antibodies"
;[1394..1408]:gene-protein:"IGF-I receptor"
(SENT
  (S
    (S-MNR
      (NP-SBJ (-NONE-:[1222..1222] *))
      (VP (VBG:[1222..1227] Using)
        (NP (VBG:[1228..1236] blocking)
          (ADJP (AFX:[1237..1241] anti) (HYPH:[1241..1242] -)
                (NN:[1242..1250] receptor))
          (NNS:[1251..1261] antibodies))))
    (,:[1261..1262] ,)
    (NP-SBJ-1
      (NP (PRP:[1264..1266] it))
      (SBAR-2 (-NONE-:[1266..1266] *EXP*)))
    (VP (MD:[1267..1272] could)
      (VP (VB:[1273..1275] be)
        (VP (VBN:[1276..1281] shown)
          (NP-1 (-NONE-:[1281..1281] *))
          (SBAR-2 (IN:[1282..1286] that)
            (S
              (NP-SBJ-3
                (NP
                  (NP (DT:[1287..1290] the) (NN:[1291..1306] differentiation))
                  (VP (VBN:[1307..1314] induced)
                    (NP (-NONE-:[1314..1314] *))
                    (PP (IN:[1315..1317] by)
                      (NP-LGS (DT:[1318..1323] these) (NNS:[1324..1331] factors)))))
                (,:[1331..1332] ,)
                (PP (IN:[1333..1335] in)
                  (NP
                    (NP (NN:[1337..1348] combination))
                    (PP (IN:[1349..1353] with)
                      (NP (NN:[1354..1357] PMA))))))
              (,:[1357..1358] ,)
              (VP (VBD:[1359..1362] was)
                (VP
                  (ADVP (RB:[1363..1372] primarily))
                  (VBN:[1373..1381] mediated)
                  (NP-3 (-NONE-:[1381..1381] *))
                  (PP (IN:[1382..1389] through)
                    (NP (DT:[1390..1393] the)
                       (NN:[1394..1399] IGF-I) (NN:[1400..1408] receptor))))))))))
    (.:[1408..1409] .)))

;section 9 Span:1413..1457
;PMID: 1946468 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1413..1417] PMID) (::[1417..1418] :) (CD:[1419..1426] 1946468)
        (NN:[1427..1428] -LSB-) (NNP:[1428..1434] PubMed) (::[1435..1436] -)
        (NN:[1437..1444] indexed) (IN:[1445..1448] for)
        (NNP:[1449..1457] MEDLINE-RSB-)))
